Advertisement

Advertisement

2020 Annual Meeting of the Society for Immunotherapy of Cancer

By Caroline Helwick / December 25, 2020 / 2020 Annual Meeting of the Society for Immunotherapy of Cancer

Intratumoral Injections May Boost Neoadjuvant Response in Resectable Melanoma

Studies reported at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting, which was held virtually, showed promise for the use of intratumoral injections of novel immunotherapies in trea...

By Caroline Helwick / December 25, 2020 / 2020 Annual Meeting of the Society for Immunotherapy of Cancer

Novel Combination Under Study in First-Line Treatment of Metastatic Melanoma

A first-line regimen combining the novel interleukin-2 (Il-2) agonist bempegaldesleukin (NKTR-214) with nivolumab showed encouraging clinical activity in patients with metastatic melanoma in the phase...

Advertisement

Advertisement

Nov

21

Today In Oncology

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors

Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC

Advertisement

© 2024 HSP News Service, L.L.C.